Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 shares of Preferred Stock and (ii) Sheffield of 12,000 shares of Common Stock and 7,224 shares of Preferred Stock, issuable as provided in Clause 4.3 hereof.
Appears in 2 contracts
Samples: Subscription, Joint Development and Operating Agreement (Sheffield Pharmaceuticals Inc), Sheffield Pharmaceuticals Inc
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 2,388 shares of Preferred Stock Shares, and (ii) Sheffield RPI of 12,000 6,000 shares of Common Stock Shares and 7,224 3,612 shares of Preferred StockShares, issuable as provided in Clause 4.3 4.4 hereof.
Appears in 2 contracts
Samples: Joint Development and Operating Agreement (Ribozyme Pharmaceuticals Inc), Joint Development and Operating Agreement (Ribozyme Pharmaceuticals Inc)
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 shares of Preferred Stock 2388 Preference Shares and (ii) Sheffield Incara of 12,000 shares of 6000 Common Stock Shares and 7,224 shares of Preferred Stock3612 Preference Shares, issuable as provided in Clause 4.3 hereof.
Appears in 1 contract
Samples: Joint Development and Operating Agreement (Incara Pharmaceuticals Corp)
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 shares of Preferred Stock 2,388 Preference Shares and (ii) Sheffield SafeScience of 12,000 shares of 6,000 Common Stock Shares and 7,224 shares of Preferred Stock3,612 Preference Shares, issuable as provided in Clause 4.3 hereof.
Appears in 1 contract
Samples: Joint Development and Operating Agreement (Safescience Inc)
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 2,388 shares of Preferred Stock and (ii) Sheffield Atrix of 12,000 6,000 shares of Common Stock and 7,224 3,612 shares of Preferred Stock, issuable as provided in Clause 4.3 4.4 hereof.
Appears in 1 contract
Samples: Joint Development and Operating Agreement (Atrix Laboratories Inc)
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 2,388 shares of Preferred Common Stock and (ii) Sheffield TGEN of 12,000 6,000 shares of Common Stock and 7,224 3,612 shares of Preferred Stock, issuable as provided in Clause 4.3 hereof.
Appears in 1 contract
Samples: Joint Development and Operating Agreement (Targeted Genetics Corp /Wa/)
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 2,980 shares of Preferred Stock and (ii) Sheffield Athersys of 12,000 shares of Common Stock and 7,224 shares of Preferred Stock, issuable as provided in Clause 4.3 4.4 hereof.
Appears in 1 contract
Samples: Joint Development and Operating Agreement (Athersys Inc /Oh)
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 2,388 shares of Preferred Stock and (ii) Sheffield Depomed of 12,000 6,000 shares of Common Stock and 7,224 3,612 shares of Preferred Stock, issuable as provided in Clause 4.3 4.4 hereof.
Appears in 1 contract
Samples: Joint Development and Operating Agreement (Depomed Inc)
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 2,388 shares of Preferred Stock Shares and (ii) Sheffield Acusphere of 12,000 6,000 shares of Common Stock Shares and 7,224 3,612 shares of Preferred StockShares, issuable as provided in Clause 4.3 hereof.
Appears in 1 contract
Samples: Joint Development and Operating Agreement (Acusphere Inc)
Authorization and Closing. 4.1 Newco has authorized the issuance to (i) EIS of 4,776 2,980 shares of Preferred Stock and (ii) Sheffield Photogen of 12,000 shares of Common Stock and 7,224 shares of Preferred Stock, issuable as provided in Clause 4.3 hereof.
Appears in 1 contract
Samples: Photogen Technologies Inc
